Cushing Syndrome: all 130 studies
Page 1 of 2. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.
- Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine DiseasesRecruitingNCT07703683
- REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)RecruitingNCT07412782Not applicable
- IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol SecretionRecruitingNCT07361874Not applicable
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)RecruitingNCT07296484Phase 2
- Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's SyndromeNot yet recruitingNCT07247162Phase 4
- Establishment and Clinical Application of Reference Intervals of Salivary CortisolRecruitingNCT07168122
- Salivary Cortisol and Hypercortisolism in Type 2 DiabetesRecruitingNCT07156370
- Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACSRecruitingNCT07138274Phase 2
- Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)RecruitingNCT07104812Phase 2
- Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal DisordersNot yet recruitingNCT06980753Not applicable
- Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CTRecruitingNCT06962202
- Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's SyndromeRecruitingNCT06801249Phase 4
- Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma DetectionNot yet recruitingNCT06701838
- Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing SyndromeRecruitingNCT06635629Phase 2
- Institutional Registry of Rare DiseasesRecruitingNCT06573723
- Dynamic Hormone Profiling and Multimodal Data Capture in Primary AldosteronismRecruitingNCT06495983
- A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid ReplacementRecruitingNCT06430528
- Study of the Steroid Hormone Milieu in Obese PatientsRecruitingNCT06341699
- Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical ModelsNot yet recruitingNCT06326853
- PATHophysiology of OSteoporosis: Role of Hidden Cortisol Excess and Its Predictors in Bone FragilityRecruitingNCT06324084
- A Single Center Randomized Controlled Study on the Promotion of Rapid RecoveryRecruitingNCT06250699Not applicable
- Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and HypercortisolismRecruitingNCT06246357Phase 2
- Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World DataRecruitingNCT06229405
- Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted AdrenalectomyRecruitingNCT06050057
- Real-time Monitoring of Cortisol - Comparison of Cortisol Levels in Four Biological FluidsRecruitingNCT06008184
- Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous HypercorticismRecruitingNCT05911620Not applicable
- NAC- NAFLD And CushingRecruitingNCT05881005Not applicable
- Type 2 Diabetes, Obesity and Cortisol ExcessRecruitingNCT05759637
- Cushing's Syndrome Before and After Treatment (CORRECT)RecruitingNCT05521529
- Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary AldosteronismRecruitingNCT05368090Not applicable
- China Adrenal Disease RegistryRecruitingNCT04890444
- Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)RecruitingNCT04543253
- Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid DisordersRecruitingNCT04374721Not applicable
- Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic AlterationsRecruitingNCT04127552
- Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's SyndromeRecruitingNCT03708900Phase 2
- A Prospective Cohort Study for Patients With Adrenal DiseasesEnrolling by invitationNCT03474237
- Collecting Information About Treatment Results for Patients With Cushing's SyndromeRecruitingNCT03364803
- Evaluation of Adults With Endocrine and Metabolic-Related ConditionsRecruitingNCT02830308
- Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing SyndromeRecruitingNCT02019706Phase 2
- Adrenal Tumors - Pathogenesis and TherapyRecruitingNCT00669266
- Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's SyndromeCompletedNCT05633953Results posted
- An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal WomenTerminatedNCT05038878Phase 4Results posted
- A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal AdenomasCompletedNCT04308590Phase 3Results posted
- A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing SyndromeCompletedNCT03697109Phase 3Results posted
- Open-label Treatment in Cushing's SyndromeCompletedNCT03621280Phase 3Results posted
- Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699CompletedNCT03606408Phase 2Results posted
- A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.CompletedNCT03277690Phase 3Results posted
- A Study of ATR-101 for the Treatment of Endogenous Cushing's SyndromeTerminatedNCT03053271Phase 2Results posted
- Study to Evaluate CORT125134 in Participants With Cushing's SyndromeCompletedNCT02804750Phase 2Results posted
- Study of Efficacy and Safety of Osilodrostat in Cushing's SyndromeCompletedNCT02468193Phase 2Results posted
- Study of Adrenalectomy Versus Observation for Subclinical HypercortisolismTerminatedNCT02001051Phase 2Results posted
- Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal HypercortisolismCompletedNCT01990560Phase 4Results posted
- Treatment for Endogenous Cushing's SyndromeCompletedNCT01838551Phase 3Results posted
- Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's SyndromeCompletedNCT01371565Phase 3Results posted
- Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine OriginTerminatedNCT00958841Phase 2Results posted
- An Extension Study of CORLUX in the Treatment of Endogenous Cushing's SyndromeCompletedNCT00936741Phase 3Results posted
- A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's SyndromeCompletedNCT00569582Phase 3Results posted
- Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) SecretionTerminatedNCT00422201Phase 2Results posted
- New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing SyndromeCompletedNCT00001849Phase 2Results posted
- Serum and Salivary Cortisol Assessment in Patients With Adrenal Incidentalomas and Healthy ControlsCompletedNCT07350031
- Contralateral Adrenal Volume Predicts Duration of Postoperative Steroid Replacement Therapy in Non-ACTH-dependent HypercortisolismCompletedNCT07282223
- Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)CompletedNCT06829537
- Canadian Continuation of Roll-over Study in Patients With Endogenous Cushing's SyndromeActive, not recruitingNCT06131580Phase 4
- Metyrapone for Mild Autonomous Cortisol Secretion (MACS)Active, not recruitingNCT06106295Phase 2
- A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's SyndromeCompletedNCT05804669Phase 1/2
- Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)CompletedNCT05772169Phase 4
- Cortisol Secretion, Sensitivity and Activity and HypertensionStatus unknownNCT05766085
- Prevalence of Hidden Hypercortisolism in OsteoporosisStatus unknownNCT05762549
- Appropriate Limit Value for 1 mg DST in Patients With Chronic Renal FailureCompletedNCT05568602
- Metabolic Myopathy in EndocrinopathyTerminatedNCT05456997
- Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden DeathActive, not recruitingNCT05446779
- Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's SyndromeActive, not recruitingNCT05382156
- First-in-human Evaluation of [18F]CETOCompletedNCT05361083Early Phase 1
- Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy ParticipantsCompletedNCT05347979Phase 1
- Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of BogotáActive, not recruitingNCT05315388Not applicable
- SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's SyndromeCompletedNCT05307328Phase 2
- Effects of Metyrapone in Patients With HypercortisolismCompletedNCT05255900
- Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole.Status unknownNCT04872920
- Effect of Surgical or Conservative Approach in Patients With Adrenal IncidentalomasStatus unknownNCT04860180Not applicable
- Genomic and Metabolomic Markers Reflecting the Complications of Hypercortisolism (CUSHINGOMICS)Active, not recruitingNCT04840693Not applicable
- Evaluation of New Diagnostic Indicator of Subclinical HypercortisolismStatus unknownNCT04833192
- Nailfold Capillaroscopy Evaluation in Cushing Syndrome PatientsStatus unknownNCT04433819
- Liquorice and Salivary CortisolStatus unknownNCT04045015Not applicable
- Cardiovascular Status in Patients With Endogenous Cortisol Excess (Cushing's Syndrome)CompletedNCT03880513
- Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's DiseaseCompletedNCT03817840
- Muscle in Acromegaly and Cushing's SyndromeStatus unknownNCT03673761
- Patient and Partner Perception After Remission of Cushing's SyndromeCompletedNCT03607474
- Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeActive, not recruitingNCT03604198Phase 2
- The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory DiseasesCompletedNCT03575247
- Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing SyndromeTerminatedNCT03379363
- The Circadian Rhythm in CusHing SyndrOme in Active Phase and dUring RemiSsion (TheHOURS)Status unknownNCT03343470
- Alterations of Muscle Secretome Associated With Muscle Atrophy Caused by GlucocorticoidsCompletedNCT03229395
- Quality of Life, Fatigue and Cognitive, Affective and Emotional Dysfunction in Patients With Cushing's SyndromeActive, not recruitingNCT03211624
- Cushing's Osteoporosis SpecificitiesCompletedNCT03162068
- Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical CarcinomaStatus unknownNCT03145285Phase 2
- Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 InhibitionCompletedNCT03111810Phase 2
- Dynamic Hormone Diagnostics in Endocrine DiseaseCompletedNCT02934399
- Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After SurgeryCompletedNCT02922257
- In Vivo Study of Interactions Between the Endocannabinoid System and the Corticotropic Axis in ManCompletedNCT02889224Not applicable
- The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome DiagnosisStatus unknownNCT02791698